Motus GI Holdings Inc
F:7M40
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Motus GI Holdings Inc
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 30 full-time employees. The company went IPO on 2018-02-14. The firm is engaged in developing a medical device Pure-Vu System. Pure-Vu system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Pure-Vu System facilitates the cleaning of the colon during the colonoscopy procedure. Pure-Vu System integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The firm is focused on GI bleeds clinical research . The firm's subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 30 full-time employees. The company went IPO on 2018-02-14. The firm is engaged in developing a medical device Pure-Vu System. Pure-Vu system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Pure-Vu System facilitates the cleaning of the colon during the colonoscopy procedure. Pure-Vu System integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The firm is focused on GI bleeds clinical research . The firm's subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
